Innovative AFP Testing Technologies and Emerging Markets
Innovative AFP Testing Technologies and Emerging MarketsReport Details:Published:November 2012No. of Pages: 248Price: Single User License – US$3850Presents a detailed analysis of the Alpha-fetoprotein testing market in the US, Europe (France,Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratorypractice; 5- and 10-year test volume and sales forecasts by country and market segment; as wellas sales and market shares for major suppliers.The cancer diagnostics market is on the verge ofexplosion, as the researchers approach major technological breakthroughs in tumor diagnosis andtherapy, discover new specific antigens, and unlock the mystery of the genetic basis of thedisease. During the next ten years, the worldwide cancer testing market is promising to be anexciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will createnumerous opportunities for determining genetic predisposition, detecting specific tumors, andmonitoring biological response to cancer therapy. The rise in geriatric population will furthercompound the growing demand for malignancy assays and the rapid market expansionworldwide.The report also examines market applications of DNA probes, biochips/microarrays,monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviewsfeatures and operating characteristics of automated analyzers; profiles leading suppliers andrecent market entrants developing innovative technologies and products; and identifies alternativemarket penetration strategies and entry barriers/risks.Get your copy of this report @http://www.reportsnreports.com/reports/207478-innovative-afp-testing-technologies-and-emerging-markets.htmlMajor points covered in Table of Contents of this report includeTable of ContentsI. IntroductionII. AFP Worldwide Market and Technology OverviewA. Alpha-Fetoprotein (AFP): Clinical Significance and Laboratory PracticesB. Instrumentation Review AndMarket Needs1. Abbott AxSYM2. Abbott Architect c4000
III. France: Market Size, Growth and Major Suppliers’Sales and Market SharesIV. Germany: Market Size, Growth and Major Suppliers’Sales and Market SharesV. Italy: Market Size, Growth and Major Suppliers’Sales and Market SharesVI. Japan: Market Size, Growth and Major Suppliers’Sales and Market SharesVII. Spain: Market Size, Growth and Major Suppliers’Sales and Market SharesVIII. U.K.: Test Volume and Diagnostics Sales Forecast by Market SegmentIX. U.S.A.: Market Size, Growth and Major Suppliers’Sales and Market SharesX. Design Criteria for Decentralized Testing ProductsXI. Alternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation FactorXII. Potential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent Protection
QiagenRadient PharmaceuticalsRocheScienionSequenomSiemens HealthcareTakara BioTargeted Diagnostics & TherapeuticsTosohVeridexWako Pure ChemicalsWallac/PEZilaList of TablesMajor Companies Developing or Marketing AFP TestsFranceAFP Test Volume and Diagnostics Sales by Market SegmentFranceAFP Testing Market by Major SupplierGermanyAFP Test Volume and Diagnostics Sales by Market SegmentGermanyAFP Testing Market by Major SupplierItalyAFP Test Volume and Diagnostics Sales by Market SegmentItalyAFP Testing Market by Major SupplierJapanAFP Test Volume and Diagnostics Sales by Market SegmentJapanAFP Testing Market by Major SupplierSpainAFP Test Volume and Diagnostics Sales by Market SegmentSpainAFP Testing Market by Major SupplierU.K.AFP Test Volume and Diagnostics Sales by Market SegmentU.S.A.AFP Test Volume and Diagnostics Sales by Market SegmentU.S.A.
AFP Testing Market by Major SupplierContact: firstname.lastname@example.org for more information.